BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8776586)

  • 41. FRAXE expansion is not a common etiological factor among developmentally delayed males.
    Allingham-Hawkins DJ; Ray PN
    Am J Hum Genet; 1995 Jul; 57(1):72-6. PubMed ID: 7541938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fragile X premutation screening in women with premature ovarian failure.
    Conway GS; Payne NN; Webb J; Murray A; Jacobs PA
    Hum Reprod; 1998 May; 13(5):1184-7. PubMed ID: 9647544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation.
    Flynn GA; Hirst MC; Knight SJ; Macpherson JN; Barber JC; Flannery AV; Davies KE; Buckle VJ
    J Med Genet; 1993 Feb; 30(2):97-100. PubMed ID: 8445629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterization of FRAXE-positive subjects with mental impairement in two unrelated Italian families.
    Russo S; Selicorni A; Bedeschi MF; Natacci F; Viziello P; Fortuna R; Pagani G; Dalprà L; Larizza L
    Am J Med Genet; 1998 Jan; 75(3):304-8. PubMed ID: 9475603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population.
    Meadows KL; Pettay D; Newman J; Hersey J; Ashley AE; Sherman SL
    Am J Med Genet; 1996 Aug; 64(2):428-33. PubMed ID: 8844098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FRAXE mutation analysis in three Spanish families.
    Carbonell P; López I; Gabarrón J; Bernabé MJ; Lucas JM; Guitart M; Gabau E; Glover G
    Am J Med Genet; 1996 Aug; 64(2):434-40. PubMed ID: 8844099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FMR2 expression in families with FRAXE mental retardation.
    Gécz J; Oostra BA; Hockey A; Carbonell P; Turner G; Haan EA; Sutherland GR; Mulley JC
    Hum Mol Genet; 1997 Mar; 6(3):435-41. PubMed ID: 9147647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FRAXE and mental retardation.
    Mulley JC; Yu S; Loesch DZ; Hay DA; Donnelly A; Gedeon AK; Carbonell P; López I; Glover G; Gabarrón I
    J Med Genet; 1995 Mar; 32(3):162-9. PubMed ID: 7783162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FRAXE mutation in a mentally retarded subject and in his phenotypically normal twin brother.
    Lo Nigro C; Faravelli F; Cavani S; Perroni L; Novello P; Vitali M; Bricarelli FD; Grasso M
    Eur J Hum Genet; 2000 Mar; 8(3):157-62. PubMed ID: 10780779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island.
    Gu Y; Shen Y; Gibbs RA; Nelson DL
    Nat Genet; 1996 May; 13(1):109-13. PubMed ID: 8673086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and validation in 500 female samples of a TP-PCR assay to identify AFF2 GCC expansions.
    Silva C; Maia N; Santos F; Rodrigues B; Marques I; Santos R; Jorge P
    Sci Rep; 2021 Jul; 11(1):14676. PubMed ID: 34282157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of the gene FMR2, associated with FRAXE mental retardation.
    Gecz J; Gedeon AK; Sutherland GR; Mulley JC
    Nat Genet; 1996 May; 13(1):105-8. PubMed ID: 8673085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amplification of the Xq28 FRAXE repeats: extreme phenotype variability?
    Murgia A; Polli R; Vinanzi C; Salis M; Drigo P; Artifoni L; Zacchello F
    Am J Med Genet; 1996 Aug; 64(2):441-4. PubMed ID: 8844100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation.
    Pandey UB; Phadke S; Mittal B
    Genet Test; 2002; 6(4):335-9. PubMed ID: 12537661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Instability of the CGG repeat at the FRAXA locus and variable phenotypic expression in a large fragile X pedigree.
    Pintado E; de Diego Y; Hmadcha A; Carrasco M; Sierra J; Lucas M
    J Med Genet; 1995 Nov; 32(11):907-8. PubMed ID: 8592340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Analysis of the allelic polymorphism of the five X-linked (CA)n dinucleotide repeats in Russia].
    Drozd OV; Strel'nikov VV; Babenko OV; Zemliakova VV; Nemtsova MV; Zaletaev DV
    Genetika; 2003 Mar; 39(3):433-8. PubMed ID: 12722645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between idiopathic premature ovarian failure and fragile X premutation.
    Marozzi A; Vegetti W; Manfredini E; Tibiletti MG; Testa G; Crosignani PG; Ginelli E; Meneveri R; Dalprà L
    Hum Reprod; 2000 Jan; 15(1):197-202. PubMed ID: 10611212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fragile X founder chromosome effects: linkage disequilibrium or microsatellite heterogeneity?
    Zhong N; Ye L; Dobkin C; Brown WT
    Am J Med Genet; 1994 Jul; 51(4):405-11. PubMed ID: 7943008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities.
    Holden JJ; Julien-Inalsingh C; Chalifoux M; Wing M; Scott E; Fidler K; Swift I; Maidment B; Knight SJ; Davies KE; White BN
    Am J Med Genet; 1996 Aug; 64(2):420-3. PubMed ID: 8844096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.